{"id": "patient_01_q4", "generated_text": "D: 6 cycles of R-Pola-CHP\n\nThe oncology board recommends six cycles of the R-Pola-CHP regimen for Mrs. Sample, indicating the continuation of the current treatment plan without further modifications. This recommendation is based", "model_name": "Qwen/Qwen2.5-1.5B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 0}, "verifier_avg_nll": 2.562131881713867}
{"id": "patient_01_q4", "generated_text": "D: Oncology board recommended 6 cycles of R-Pola-CHP for Mrs. Sample. The patient was also advised to pause fingolimod re-evaluation in 4-5 months, continue therapy near residence in the clinic,", "model_name": "Qwen/Qwen2.5-3B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 0}, "verifier_avg_nll": 3.370732069015503}
{"id": "patient_01_q4", "generated_text": "D: 6 cycles of R-Pola-CHP\nAnswer:  D: 6 cycles of R-Pola-CHP\n\nBased on the context provided, the oncology board decision is clearly stated in the document: \"Onc", "model_name": "Qwen/Qwen2.5-7B-Instruct", "generation_params": {"temperature": 0.7, "max_new_tokens": 50, "top_p": 0.9, "index": 0}, "verifier_avg_nll": 2.7655980587005615}
